Pharmaceuticals and Vaccines

Event

Open Minds, Open Labs: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World

This meeting is part of the CEO speaker series. This series provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.

See more in Global; Diseases, Infectious; Pharmaceuticals and Vaccines

Event

Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization?

Session One
The Scale of the Challenge: Overview and Case Studies
Welcoming Remarks: Richard N. Haass, President, Council on Foreign Relations
Opening Remarks: Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
David Heymann
, Head and Senior Fellow, Centre on Global Health Security, Chatham House, United Kingdom
Gary Jay Kushner, Partner and Leader, Food and Agriculture Practice Area, Hogan Lovells US, LLP
Paul B. Orhii, Director General, National Agency for Food and Drug Administration and Control, Nigeria
Presider: Richard E. Besser, Chief Health and Medical Editor, ABC News
8:15 to 9:00 AM Breakfast Reception
9:00 to 10:30 AM Meeting

Session Two
Policy Challenges in a Globalized Era

Dirceu Barbano, Director-President, National Agency of Sanitary Surveillance, Brazil
Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
Howard Zucker, Senior Adviser, Division of Global Health and Human Rights, Massachusetts General Hospital; Former Assistant Director-General, World Health Organization
Presider: Susan Dentzer, Editor-in-Chief, Health Affairs
10:45 AM to 12:00 PM Meeting

Session Three
Potential Solutions

Caroline Smith DeWaal
, Food Safety Director, Center for Science in the Public Interest
Aline Plan
çon, Head of INTERPOL-IMPACT Project and Head of Medical Products Counterfeiting, and Pharmaceutical Crime Unit (MPCPC), INTERPOL, France
Michael Robach, Vice President, Corporate Food Safety and Regulatory Affairs, Cargill, Inc.
Greg Simon, Senior Vice President, Worldwide Policy, Pfizer, Inc.
Presider and Closing Remarks: Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations
12:00 to 12:45 PM Lunch
12:45 to 2:00 PM Meeting

Related Reading:
Backgrounder: Food and Drugs by Laurie Garrett and Yanzhong Huang

See more in Global; Pharmaceuticals and Vaccines